Bioplastics from Tobacco
Metabolix, Inc., Cambridge, Mass., has just completed a field trial of growing tobacco that was genetically engineered to produce polyhydroxyalkanoate (PHA) biopolymers.
Metabolix, Inc., Cambridge, Mass., has just completed a field trial of growing
tobacco that was genetically engineered to produce polyhydroxyalkanoate (PHA)
biopolymers. The trial was performed on 0.8 acres and yielded tobacco plants
containing up to 3% to 5% of PHA. This trial lays the groundwork for future trials
of growing PHA in bioengineered, nonfood oilseed and biomass crops such as
switchgrass and sugarcane.
Metabolix previously developed genetically engineered bacteria that produce
PHA inside their cell walls by fermenting cornstarch. This method is used to produce
Mirel bioplastic for Telles in Lowell, Mass., a joint venture of Metabolix and Archer Daniels Midland.
(617) 492-0505 • metabolix.com
(978) 513-1865 • mirelplastics.com
Related Content
-
Injection Molding Stock-Shape Parts in High-Temperature Materials
Patented technology is described as a hybrid that uses a specialized tool, a standard injection molding machine and off-the-shelf components to replace compression molding and extrusion for large stock shapes.
-
ICIS Launches: Ask ICIS Generative AI Commodities Assistant
Said to be the first of its kind, this AI assistant will enhance access to ICIS’ intelligence and insights for the energy and chemical markets.
-
BASF Highlighting How They 'Make, Use and Recycle Future Solutions'
NPE2024: BASF is using its proprietary computer-aided engineering tool Ultrasim when designing for sustainability in a broad range of industries.
